Application of rape receptor gene BnRLP41 in prevention and control of sclerotiniose

By cloning and applying the rapeseed receptor gene BnRLP41, overexpression and CRISPR knockdown of genetically modified rapeseed, the problem of prevention and control of rapeseed fungi is solved, efficient and safe green prevention and control is achieved, the breeding process is simplified, and high antibacterials is provided. New materials and new varieties of nuclear diseases.

CN118910140AActive Publication Date: 2024-11-08ZHEJIANG UNIV

Patent Information

Application Number
CN202411163677.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-23
Publication Date
2024-11-08
Estimated Expiration
2044-08-23

AI Technical Summary

Technical Problem

The existing technology is difficult to effectively prevent and control sclerosis in rapeseed, and lacks high-resistant varieties. Chemical prevention and control has problems with ecological pollution and drug resistance, and new disease-resistant gene resources are needed.

Method used

By cloning the rapeseed receptor gene BnRLP41, it constructs its overexpression and CRISPR knockdown of transgenic rapeseed, enhancing or weakening resistance to sclerotis, and creating rapeseed materials with high or low resistance.

Benefits of technology

The regulatory effect of the BnRLP41 gene on the resistance to sclerosis of rapeseed bacteria was successfully clarified, providing an efficient and safe green prevention and control pathway, and obtaining new rapeseed materials and new varieties with high antibacterial sclerosis, simplifying the breeding process.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure HDA0005007204360000011
    Figure HDA0005007204360000011
  • Figure HDA0005007204360000012
    Figure HDA0005007204360000012
Patent Text Reader

Abstract

The invention provides an application of a brassica napus receptor-like gene BnRLP41 in prevention and control of sclerotiniose, which is an application in obtaining a brassica napus material with changed disease resistance by creating transgenic brassica napus. According to the invention, overexpression of BnRLP41 and CRISPR gene knockout transgenic oilseed rape are constructed, a positive regulation function of the gene on sclerotiniose resistance is disclosed for the first time, and application of the BnRLP41 gene to acquisition of a high sclerotiniose resistance oilseed rape material through creation of overexpression oilseed rape is provided. The invention also discloses an application of the BnRLP41-CRISPR gene knockout rape to obtain the sclerotinia sclerotiorum rape material with weakened sclerotinia sclerotiorum resistance. The BnRLP41 gene provided by the invention is a new gene resource suitable for creating and breeding new sclerotiniose-resistant rape materials and new varieties.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of biotechnology and relates to application of a rapeseed receptor gene BnRLP41 in the prevention and control of sclerotinia disease. Background Art

[0002] 1. Plant gene function analysis technology Plant gene function is usually determined and clarified by comparing and analyzing the phenotype or function of the gene under abnormal expression and normal expression. The abnormal expression of genes includes two categories: expression above normal level and expression below normal level. Expression above normal level is mainly over-expression, which is mainly achieved by connecting a strong promoter to drive the expression of the target gene. Expression below normal level is mainly achieved by RNA interference (RNAi), gene knockout and other methods. RNAi is achieved by constructing and transforming a hairpin structure containing an intron or other non-expressed sequence inserted in the opposite direction of the same sequence fragment, resulting in a decrease in the expression of the target gene. Gene knockout is achieved by inserting a long non-plant sequence into the target gene in the plant genome or removing the target gene, resulting in complete or nearly complete inhibition of the expression of the target gene. By constructing gene overexpression plants and / or RNAi plants, gene knockout mutants, and comparing and analyzing the differences in their phenotypes and traits with those of wild-type / normal plants, the regulatory function of the target gene on the trait can be clarified.

[0003] 2. Genetic regulation technology for plant disease resistance Plant disease resistance is the result of plant receptors recognizing pathogen ligands and activating disease resistance signal transduction and a series of defense responses. From a genetic point of view, after receptor-ligand recognition, disease resistance signal transduction is activated, activating immune disease resistance responses. When plants face pathogen invasion, the pattern recognition receptors on the surface of plant cell membranes specifically recognize the conserved molecular patterns of pathogens to activate the first layer of the innate immune system. Pathogen recognition and signal transduction and activation of intracellular disease resistance pathways are crucial for the generation of disease resistance responses. Receptor-like protein (RLP) is one of the two major types of receptors currently known for plant recognition of pathogen molecular patterns. Using RLP genes to create crop germplasm with enhanced disease resistance is expected to be effective, but there are currently very few public reports in this regard.

[0004] 3. Plant Sclerotinia disease prevention and control technology Plant sclerotinia is caused by infection by Sclerotinia sclerotiorum. Sclerotinia sclerotiorum is a necrotrophic pathogenic fungus with a very wide host range. It is a major disease of oil crops and vegetable crops. It causes huge economic losses every year. Due to the lack of highly resistant varieties, chemical control is still an important means. Since some pesticides have problems such as ecological pollution, toxicity to humans and animals, and easy to make pathogens resistant, identifying important anti-sclerotinia regulatory genes and creating and using disease-resistant varieties are crucial for the green prevention and control of sclerotinia.

[0005] 4. Plant disease resistance breeding technology Plant disease resistance breeding technology is mainly divided into two categories: traditional disease resistance breeding and disease resistance breeding through genetic engineering. Traditional disease resistance breeding has natural genetic isolation, which significantly limits the scope of available disease resistance resources. It can only apply disease resistance resources with close genetic relationships, and requires multiple hybridization and backcrossing, etc. Therefore, the breeding cycle is long and requires a lot of manpower and material resources. The genetic engineering breeding method is to introduce exogenous disease resistance regulatory genes into plants through Agrobacterium-mediated methods and other technologies to enable them to obtain disease resistance that they did not originally have. Therefore, the genetic engineering breeding method breaks the limitations of natural genetic isolation, broadens the scope of available disease resistance resources, and has the characteristics of relatively simple and convenient operation, short cultivation cycle, and no need for a lot of manpower and material resources. In addition, varieties with broad-spectrum disease resistance can be created by introducing a broad-spectrum disease resistance regulatory gene, or multiple genes with different disease resistance spectra. Therefore, it has the advantages of being particularly suitable for cultivating broad-spectrum and long-lasting disease-resistant varieties. Summary of the invention

[0006] The present invention aims to provide an application of a rapeseed receptor gene BnRLP41 in the prevention and control of sclerotinia disease. The rapeseed receptor gene BnRLP41 has a regulating function on disease resistance and can be applied to the creation of crop germplasm resistant to Sclerotinia sclerotiorum.

[0007] The application is to obtain rapeseed materials with altered disease resistance by creating transgenic rapeseed, to obtain rapeseed materials with enhanced sclerotinia resistance by creating transgenic rapeseed overexpressing BnRLP41, or to obtain rapeseed materials with weakened sclerotinia resistance by creating BnRLP41-CRISPR gene knockout transgenic rapeseed.

[0008] The present invention uses the cDNA of the double 11 variety in rapeseed (Brassica napus) as a template, and obtains the rapeseed gene BnRLP41 by PCR cloning, the nucleotide sequence of which is shown in SEQ ID: 1, the open reading frame (ORF) of the gene is 2655bp long, and the encoded protein consists of 884 amino acids, and its sequence is shown in SEQ ID: 2. The BnRLP41 protein contains an LRR domain. The nucleotide sequence cloned by the present invention is consistent with the LOC106447094 nucleotide sequence of the rapeseed variety ZS11 in the NCBI database, and the protein sequence is the same as XP_013744403.2.

[0009] Prior to the present invention, there was no public report on the function of this gene. This invention, for the first time, clarified the regulatory effect of this gene on rapeseed's resistance to Sclerotinia sclerotiorum by constructing overexpression and CRISPR knockout transgenic rapeseed and analyzing its disease resistance. The results showed that compared with wild-type rapeseed plants, overexpression transgenic rapeseed plants were significantly more resistant to Sclerotinia sclerotiorum, while knockout transgenic plants were significantly more susceptible to Sclerotinia sclerotiorum, indicating that BnRLP41 positively regulates rapeseed's resistance to Sclerotinia sclerotiorum.

[0010] Based on the BnRLP41 gene function explained in the present invention, the application purpose of the present invention is to provide the application of the rapeseed BnRLP41 gene in obtaining rapeseed materials with altered disease resistance by creating transgenic rapeseed, including (1) application in obtaining rapeseed materials with increased resistance to sclerotinia by creating transgenic rapeseed overexpressing BnRLP41 (Example 1); and (2) application in obtaining rapeseed materials with reduced resistance to sclerotinia by creating transgenic rapeseed with BnRLP41-CRISPR gene knockout (Example 2).

[0011] The application of the rapeseed BnRLP41 gene in obtaining a rapeseed material with enhanced resistance to sclerotinia sclerotiorum by creating a transgenic rapeseed overexpressing BnRLP41 is specifically achieved by the following steps: (1) Construction and acquisition of BnRLP41 gene overexpression structure: The BnRLP41 gene open reading frame (ORF) was cloned into a plant expression vector so that it was expressed under the drive of a strong promoter; (2) Obtaining Agrobacterium for transformation of BnRLP41 gene overexpression structure: The constructed BnRLP41 gene overexpression structure is transformed into an Agrobacterium strain with strong infection ability to rapeseed by methods such as electric shock; (3) Creation and acquisition of transgenic rapeseed overexpressing BnRLP41: The BnRLP41 gene overexpression structure was introduced into rapeseed by Agrobacterium-mediated method to obtain the BnRLP41 gene overexpression structure of rapeseed; (4) Obtaining homozygous transgenic rapeseed lines overexpressing BnRLP41: Using antibiotic resistance and BnRLP41 gene expression as detection indicators, the trait segregation of the offspring of transgenic plants was detected, and homozygous transgenic rapeseed lines overexpressing BnRLP41 were obtained, in which the offspring traits no longer segregated and could be stably inherited; (5) Screening, identification and acquisition of homozygous transgenic rapeseed lines overexpressing BnRLP41 with enhanced resistance to sclerotinia sclerotinia: Using homozygous transgenic rapeseed lines overexpressing BnRLP41 as materials, the resistance to sclerotinia sclerotinia was detected and analyzed, and transgenic rapeseed with the BnRLP41 gene with enhanced disease resistance was obtained.

[0012] The application of the rapeseed BnRLP41 gene in obtaining rapeseed materials with reduced resistance to sclerotinia sclerotiorum by creating transgenic rapeseed with BnRLP41-CRISPR gene knockout is achieved by the following steps: (1) Construction and acquisition of the CRISPR knockout structure of the BnRLP41 gene: Three 20 bp knockout targets were preset according to the BnRLP41 genome sequence, and the target sequences were cloned into the plant expression vector pBSbdcas9i. The recombinant structure pBSbdcas9i-BnRLP41 was obtained through colony PCR identification and sequencing; (2) Obtaining Agrobacterium transformed with the CRISPR knockout structure of the BnRLP41 gene: The CRISPR knockout structure of the BnRLP41 gene (pBSbdcas9i-BnRLP41) was transformed into an Agrobacterium strain with strong infection ability to rapeseed by electroporation or other methods; (3) Creation and acquisition of rapeseed with CRISPR knockout structure of BnRLP41 gene: The CRISPR knockout structure of BnRLP41 gene was introduced into rapeseed by Agrobacterium-mediated method to obtain rapeseed with CRISPR knockout structure of BnRLP41 gene; (4) Obtaining homozygous lines of rapeseed with the CRISPR knockout structure of the BnRLP41 gene: Screening with antibiotic resistance, detecting the trait segregation of the offspring of transgenic plants, and obtaining homozygous lines of rapeseed with the CRISPR knockout structure of the BnRLP41 gene, in which the offspring traits no longer segregate and can be stably inherited; (5) Screening, identification and acquisition of homozygous rapeseed lines with CRISPR knockout structure of BnRLP41 gene and reduced resistance to sclerotinia sclerotinia: The homozygous rapeseed lines with CRISPR knockout structure of BnRLP41 gene (pBSbdcas9i-BnRLP41) were used as materials to detect and analyze the resistance to sclerotinia sclerotinia, and obtain BnRLP41 gene CRISPR knockout rapeseed with reduced resistance to sclerotinia sclerotinia.

[0013] Advantages of the present invention: (1) The BnRLP41 gene provided by the present invention is a high-quality anti-bacterial sclerotinia gene resource, and the disease-resistant materials obtained using the gene have the advantages of strong disease resistance. Rapeseed sclerotinia resistance is a quantitative trait resistance, which is controlled by multiple genes. Generally speaking, the degree of regulation of this resistance by a single gene is low. Therefore, rapeseed sclerotinia resistance materials are very scarce worldwide, and there is no highly resistant material. The BnRLP41 gene encodes a receptor-like protein, which is a receptor gene that recognizes pathogen molecular patterns and has a good resistance stimulation effect. Therefore, it is a high-quality disease-resistant gene resource. Using RLP to create disease-resistant varieties and germplasm is an economical, effective and safe way to greenly prevent and control diseases. Therefore, the BnRLP41 gene is a brand-new gene resource suitable for creating and breeding new materials and new varieties of rapeseed resistant to sclerotinia. (2) The cycle for obtaining disease-resistant materials is short. The methods for obtaining disease-resistant plant materials and varieties mainly include conventional traditional breeding methods and genetic engineering breeding methods using disease-resistant regulatory genes. Traditional breeding methods have the disadvantages of limited range of available disease-resistant resources by natural genetic isolation, long breeding cycle, and requiring a lot of manpower and material resources. Genetic engineering breeding methods have the advantages of wide range of available disease-resistant resources, relatively simple and convenient operation, short breeding cycle, no need for a lot of manpower and material resources, and are particularly suitable for breeding broad-spectrum, durable, and highly disease-resistant varieties. The present invention utilizes the disease-resistant regulatory gene BnRLP41 and adopts genetic engineering methods to create and cultivate rapeseed materials with high resistance to bacterial sclerotinia, which has the characteristics of short cycle and rapid breeding. BRIEF DESCRIPTION OF THE DRAWINGS

[0014] Figure 1 The identification evidence of various transgenic rapeseed plants obtained by the present invention is provided, showing the results of BnRLP41 gene expression detection in overexpressed plants and the gene editing form of gene knockout plants. Real-time fluorescence quantitative PCR was used to detect the expression level of BnRLP41 gene in overexpressed (OE) plants with silenced BnRLP41 gene (A), with rapeseed BnACTIN7 as the internal reference gene, and the expression level of ZS11 was set to 1. The qRT-PCR analysis was performed three times biologically, each time including three technical replicates, and the expression results were statistically analyzed by Student's t-test using GraphPad Prism, and the data were expressed as mean ± standard deviation. The significant difference is indicated by * (**, P<0.01; ***, P<0.001). The results showed that the expression levels of BnRLP41 in the two overexpression lines #7 and #18 were significantly increased, 10.5 times and 189.5 times that of the control, respectively (A). The knockout mutant strain lacks a 10 bp sequence at the target site 1 of the BnRLP41 gene, resulting in the inability to normally encode a functional BnRLP41 gene (B), indicating that these plants are true BnRLP41 gene overexpression plants and CRISPR knockout plants.

[0015] Figure 2 Evidence for the anti-sclerotinia function of the BnRLP41 gene was provided, indicating that BnRLP41 positively regulates rapeseed's resistance to Sclerotinia sclerotiorum. The rapeseed BnRLP41 transgenic plants were inoculated with Sclerotinia sclerotiorum UF-1. The figure shows the quantitative statistical analysis results of the phenotype, lesion area and mycelial biomass of BnRLP41 overexpressing plants (A) and knockout mutant plants (B) after inoculation. The inoculation experiment was repeated three times. The Student's t-test was used to analyze the lesion area using GraphPad Prism, and the data are expressed as mean ± standard deviation. The significance of the difference is indicated by different numbers of * (*, P<0.05; **, P<0.01; ***, P<0.001, ****, P<0.0001). The results showed that the overexpressing plants showed a more disease-resistant phenotype than the control (ZS11) plants (A), while the knockout mutant plants were significantly more susceptible than the control (B). The quantitative analysis results of the lesion area showed that the lesion areas of the two strains of overexpression plants were 85.1 mm 2 and 74.9mm 2 , which is significantly smaller than the control group (159.1 mm) 2 , only 53% and 47% of the control; bacterial count determination also showed that the bacterial count in the lesions of the overexpression plants was significantly lower than that of the control plants. The lesion area of ​​the knockout mutant strain was 170.6 mm 2 , significantly higher than the control group of 129.4 mm 2 , which was 1.32 times that of the control; the bacterial load determination also showed that the bacterial load in the lesions of the knockout mutant plants was significantly higher than that of the control plants. These results indicate that BnRLP41 positively regulates rapeseed's resistance to Sclerotinia sclerotiorum. DETAILED DESCRIPTION

[0016] The present invention is further described in conjunction with the accompanying drawings and embodiments.

[0017] Example 1 The present invention cloned a rapeseed gene BnRLP41, and for the first time, clarified the positive regulatory function of the gene in resisting sclerotinia by constructing overexpressed transgenic rapeseed. Overexpression of the BnRLP41 gene leads to a significant increase in the resistance of rapeseed to sclerotinia. Therefore, a new rapeseed material with enhanced resistance to sclerotinia can be created by constructing a homozygous rapeseed line overexpressing the BnRLP41 gene, which can be used for the creation and breeding of sclerotinia-resistant rapeseed varieties, analysis of gene functions and mechanisms of action, and the like. The main steps of cloning the BnRLP41 gene, analyzing its function and mechanism, and creating and obtaining new rapeseed materials with enhanced resistance to sclerotinia include:

[0018] 1) Cloning and conservation of the rapeseed BnRLP41 gene The rapeseed BnRLP41 gene provided by the present invention is cloned by the following steps: firstly, primers BnRLP41-F (5'-atg tct gaa tcc cgt gtg cgt ttg-3') (sequence as shown in SEQ ID: 3) and BnRLP41-R (5'-cta acg gtt tct gct ctt gt-3') (sequence as shown in SEQ ID: 4) are designed according to the BnRLP41 sequence in the rapeseed genome database. TRIZOL reagent was used to extract total RNA from the leaves of rapeseed variety Zhong Shuang 11, and the high-fidelity enzyme pfu-mediated RT-PCR method was used to amplify and obtain BnRLP41 cDNA. The PCR product was recovered by 1% agarose gel electrophoresis and then purified by gel cutting, connected to the pEASY-Blunt Cloning Vector vector, and transformed into Escherichia coli DH5α by heat shock. The bacteria were cultured overnight in LB medium, and the plasmid was extracted. The PCR method using BnRLP41-F / BnRLP41-R as the primer pair was used to test whether the extracted plasmid contained the BnRLP41 gene. Finally, it was sent to the company for sequencing verification, thereby successfully cloning and obtaining the full-length cDNA sequence of the BnRLP41 gene. The nucleotide sequence of BnRLP41 is shown in SEQ ID: 1, the open reading frame (ORF) of the gene is 2655bp long, and the encoded protein consists of 884 amino acids, and its sequence is shown in SEQ ID: 2. The gene encoding product contains the LRR domain. BLAST analysis revealed that the nucleotide sequence of the cloned gene was consistent with the nucleotide sequence of LOC106447094 of rapeseed variety ZS11 in the NCBI database, and the protein sequence was the same as XP_013744403.2. Prior to the present invention, there was no public report on the function of this gene.

[0019] E. coli carrying the pEASY-BnRLP41 vector were transformed and stored in a -80°C refrigerator. The BnRLP41 gene can be subcloned into the target vector at any time by activating the strain, extracting the plasmid, and PCR amplification for transgenic research.

[0020] 2) Construction and acquisition of BnRLP41 gene overexpression structure According to the cloned BnRLP41 sequence of the present invention, primers BnRLP41-F2 (5'-gacgatgataagggcggtacc tct gaa tcc cgt gtg cgt ttg-3', the italic part is a sequence containing a Kpn I restriction site and consistent with the sequence on the vector pCAMBIA1300) (the sequence is shown in SEQ ID: 5) and BnRLP41-R2 (5'-gtcctaggctacgtaggatcc cta acg gtt tct gct ctt gtt cg-3', the italic part is a sequence containing a Bam HI restriction site and consistent with the sequence on the linearized vector pCAMBIA1300) (the sequence is shown in SEQ ID: 6) were designed. The pEASY-BnRLP41 plasmid obtained in 1) of Example 1 was used as a template and BnRLP41-F2 / BnRLP41-R2 was used as a primer pair to obtain the target gene by PCR amplification.

[0021] The overexpression vector pCAMBIA1300 plasmid was double-digested with Kpn I and Bam HI, and the amplified target gene was homologously recombined with the pCAMBIA1300 vector after digestion. The reagents used in this experiment were PCR one-step directional cloning kit. The ligation product was transformed into E. coli, screened on kanamycin plates, identified by PCR and sequenced to obtain the BnRLP41 gene overexpression structure pCAMBIA1300-BnRLP41. The overexpression vector pCAMBIA1300 drives the expression of the target gene with the CaMV 35S promoter and carries a FLAG tag to facilitate molecular identification and gene function research.

[0022] 3) Obtaining Agrobacterium transformed with the BnRLP41 gene overexpression construct pCAMBIA1300-BnRLP41 The BnRLP41 gene overexpression structure pCAMBIA1300-BnRLP41 was transformed into an Agrobacterium strain with strong infectivity to rapeseed, such as EHA105, by electroporation and other methods, and the transformants were screened on YEP medium containing kanamycin, and then the Agrobacterium carrying the BnRLP41 gene overexpression structure pCAMBIA1300-BnRLP41 was obtained by double restriction digestion with KpnI and Bam HI and PCR identification. It was used for the genetic transformation of rapeseed in the next step.

[0023] 4) Creation and acquisition of the BnRLP41 gene overexpression construct pCAMBIA1300-BnRLP41 in rapeseed The BnRLP41 gene overexpression construct pCAMBIA1300-BnRLP41 was introduced into rapeseed by Agrobacterium-mediated method to obtain the rapeseed T0 generation transformed with pCAMBIA1300-BnRLP41. The specific operation steps are as follows:

[0024] (i) Seed cleaning and germination 75% ethanol for 30-60s, sterile water once, 1min / time; 0.15% mercuric chloride for 10min, wash twice with sterile water, 1min / time; wash with sterile water for 30min, inoculate on sterile filter paper and dry; inoculate the seeds in culture bottles and culture in the dark at 23℃ for 5-6d.

[0025] (ii) Pre-culture The germinated hypocotyls of rapeseed seedlings were cut into 0.4-0.6 cm segments, inoculated into pre-culture medium, and cultured at 23°C for 2-3 days.

[0026] (iii) Agrobacterium infection and co-cultivation Pick Agrobacterium in the infection solution and prepare OD 600 = 0.2 Agrobacterium resuspension, inoculate the explants in the Agrobacterium suspension for 10 minutes, inoculate the infected explants on sterile filter paper to dry, inoculate on co-culture medium, and culture at 23°C in the dark for 48-72 hours.

[0027] (iv) Degerming (extended screening) The co-cultivated explants were inoculated on sterile culture medium and cultured at 23°C under light for 6 days.

[0028] (v) Screening / differentiation The sterilized explants were inoculated on screening / differentiation medium, 30 explants per dish, cultured at 23°C under light, and the plate was changed every 15 days.

[0029] (vi) Rooting culture The differentiated buds were inoculated into rooting medium and cultured at 23°C under light until roots formed.

[0030] (vii) Detection The CTAB method was used to extract rapeseed genomic DNA, and PCR was used to detect resistance genes.

[0031] (viii) Soil Planting After the kanamycin-resistant seedlings have grown a complete root system, the T0 generation sterile seedlings are incubated with the lid open at 27°C for 2 days, then transplanted into the soil, placed in an incubator for routine management, and finally harvested to obtain T0 seeds.

[0032] 5) Screening, identification and acquisition of homozygous rapeseed lines transformed with the BnRLP41 gene overexpression construct pCAMBIA1300-BnRLP41 Kanamycin resistance and BnRLP41 gene expression were used as detection indicators to detect the segregation of traits in the offspring of transgenic plants. Kanamycin resistance screening was performed on rapeseed seeds on plates containing kanamycin to observe whether they could grow normally into healthy seedlings on kanamycin-resistant plates. Gene expression was detected using methods such as real-time fluorescence quantitative PCR. Obtained rapeseed homozygous lines of the BnRLP41 gene overexpression structure pCAMBIA1300-BnRLP41, whose offspring traits no longer separated and could be stably inherited.

[0033] The present invention obtains two BnRLP41 overexpression rapeseed homozygous lines, OE-line 7 and OE-line 18, which can all grow normally into healthy seedlings on kanamycin resistance plates, and the BnRLP41 gene expression levels are significantly higher than those of the control plants, which are 10.5 times and 189.5 times ( Figure 1 A). These plants are true BnRLP41 gene overexpressing plants.

[0034] 6) Disease resistance analysis of homozygous rapeseed lines overexpressing BnRLP41 gene The homozygous rapeseed line overexpressing the BnRLP41 gene obtained in 5) was used as material, and its resistance to rapeseed sclerotinia sclerotiorum was detected and analyzed by inoculating it with Sclerotinia sclerotiorum, thereby clarifying the regulatory role of the BnRLP41 gene on rapeseed sclerotinia sclerotiorum resistance, laying the foundation for using this gene to create and obtain rapeseed resistant to sclerotinia sclerotiorum.

[0035] Activation culture of Sclerotinia sclerotiorum: Select full and uncontaminated sclerotia of Sclerotinia sclerotiorum, cut the sclerotia into two halves with a sterile blade burned by an alcohol lamp, place them with the cut surface facing down on a PDA solid plate, and culture them at 23℃ in the dark for 3 days. Use a 4mm diameter puncher to punch out mycelium blocks 3 to 5mm inward from the edge of the colony, and inoculate them with the mycelium side facing down on a new PDA solid plate. Culture them at 23℃ in the dark for about 36 hours before inoculation.

[0036] Inoculation of Sclerotinia sclerotiorum: Select rape plants with consistent growth for inoculation. Use a 4mm diameter puncher to punch out hyphae blocks 3-5mm inward from the edge of the colony, and inoculate them with the hyphae facing down into the middle of fully developed leaves. Inoculate one hyphae block symmetrically on each half of each leaf, cover with film to keep moisture, and place in a 23℃ greenhouse for cultivation. Take photos and record after an appropriate time (about 24 hours), and analyze the lesion area using ImageJ software.

[0037] The inoculation experiment was repeated three times. The lesion area was statistically analyzed by Student's t-test. The results showed that the BnRLP41 overexpressing plants were significantly more resistant to the disease than the non-transgenic control plants (ZS11). Figure 2A). Quantitative analysis of the lesion area showed that the lesion area of ​​the ZS11 control plant was 159.1 mm 2 The lesion areas of the two strains of overexpression plants were 85.1 mm 2 and 74.9mm 2 , only 53% and 47% of the control ( Figure 2 B).

[0038] These results show that the resistance of BnRLP41 overexpressing plants to sclerotinia is significantly higher than that of non-transgenic control plants. Overexpression of the BnRLP41 gene leads to a significant increase in the resistance of rapeseed to sclerotinia, so BnRLP41 plays a positive regulatory role in the resistance of rapeseed to sclerotinia. The present invention successfully creates a new rapeseed material with high resistance to sclerotinia by constructing BnRLP41 overexpressing rapeseed.

[0039] Example 2 Based on the positive regulatory function of the rapeseed gene BnRLP41 on sclerotinia resistance explained in the present invention, a technical system for constructing CRISPR knockout transgenic rapeseed of the gene and using genetic engineering technology to create and obtain new rapeseed materials with reduced sclerotinia resistance has been established. The main steps include:

[0040] (1) Construction and acquisition of CRISPR knockout construct of BnRLP41 gene Three suitable target sites were designed according to the BnRLP41 genome sequence. Each gRNA unit contained a 20 bp gRNA and a gRNA backbone. The three gRNA units were combined as a complete silencing sequence, which was used as a template and amplified using primers BnRLP41-CR-F (5'-cag tgg tct cat gca cca ata cct cta gcc tgt tg-3', the italic part is a sequence containing Bsa I or Eco31 I restriction site and consistent with the linearized vector pBSbdcas9i) (sequence as shown in SEQ ID: 7) and BnRLP41-CR-R (5'-cag tgg tct caa aac gta aga tcg ttt cca ctt ag-3', the italic part is a sequence containing Bsa I or Eco31 I restriction site and consistent with the linearized vector pBSbdcas9i) (sequence as shown in SEQ ID: 8). The vector pBSbdcas9i was digested with Bsa I or Eco31 I, and recombined with T4 ligase, followed by transformation and kanamycin medium plate screening. Positive single clones were picked and PCR identified using pBSbdcas9i identification primers Pbw2+(5'-gca acg ctc tgt cat cgt tac aat-3') (sequence as shown in SEQ ID: 9) and M49452(470C):(5'-cta cgg ttc aag aaa atg taa gct gat-3') (sequence as shown in SEQ ID: 10), and further sequenced and identified to obtain the CRISPR knockout structure pBSbdcas9i-BnRLP41.

[0041] (2) Obtaining Agrobacterium transformed with the CRISPR knockout construct of the BnRLP41 gene The BnRLP41 gene CRISPR knockout structure (pBSbdcas9i-BnRLP41) was transformed into an Agrobacterium strain with strong infection ability to rapeseed, such as EHA105, by electroporation and other methods. The transformants were screened on YEP medium containing kanamycin and then identified by PCR to obtain Agrobacterium carrying the BnRLP41 gene CRISPR knockout structure pBSbdcas9i-BnRLP41.

[0042] (3) Creation and acquisition of BnRLP41 gene CRISPR knockout rapeseed The BnRLP41 gene CRISPR knockout structure pBSbdcas9i-BnRLP41 was introduced into rapeseed by Agrobacterium-mediated method to obtain the rapeseed T0 generation transformed with pBSbdcas9i-BnRLP41. The specific operation steps are the same as those described in 4) of Example 1. BnRLP41-CR-F2 (5'-gaa ctc tga atc ​​cca aca gta ct-3') (sequence as shown in SEQ ID: 11) and BnRLP41-CR-R2 (5'-gca gtc tga taa ctg caa ata ctc-3') (sequence as shown in SEQ ID: 12) were used to detect whether the transformed seedlings were BnRLP41 gene-edited seedlings. Subsequently, the gene-edited seedlings were sequenced near the target site, and finally determined to be mutant plants with successful knockout of the BnRLP41 gene.

[0043] (4) Obtaining homozygous rapeseed lines with CRISPR knockout of BnRLP41 gene The segregation of traits of the offspring of transgenic plants was detected by antibiotic resistance screening. The test was carried out on rapeseed seeds on plates containing Basta resistance to observe whether they can grow normally into healthy seedlings on Basta resistance plates. The homozygous rapeseed lines with the BnRLP41 gene CRISPR knockout structure pBSbdcas9i-BnRLP41, whose offspring traits no longer separated and could be stably inherited, were obtained. All these rapeseed homozygous lines can grow normally into healthy seedlings on Basta resistance plates.

[0044] The present invention obtains a BnRLP41-CRISPR gene knockout rapeseed homozygous line, which can grow normally into healthy seedlings on a Basta resistance plate. The gene knockout mutant strain lacks a 10bp sequence at the target site 1 of the BnRLP41 gene, resulting in the inability to normally encode a functional BnRLP41 gene (B). This indicates that these plants are true BnRLP41 gene CRISPR knockout plants.

[0045] (5) Screening, identification and acquisition of homozygous rapeseed lines with reduced resistance to sclerotinia sclerotinia by CRISPR knockout of the BnRLP41 gene The homozygous rapeseed line transformed with the BnRLP41 gene CRISPR knockout structure (pBSbdcas9i-BnRLP41) was used as the material to detect and analyze the resistance to sclerotinia. The inoculation method and disease resistance evaluation were the same as those described in 6) of Example 1).

[0046] The results of the Sclerotinia inoculation analysis of the BnRLP41-CRISPR gene knockout plants constructed by the present invention showed that the BnRLP41-CRISPR gene knockout plants were significantly more susceptible to the disease than the non-transgenic plants (ZS11) control ( Figure 2B) Quantitative analysis of the lesion area showed that the lesion area of ​​the ZS11 control plant was 129.4 mm 2 , while the lesion area of ​​the knockout mutant strain was 170.6 mm 2 , which was significantly higher than that of the control plants ( Figure 2 B). It shows that the resistance of BnRLP41-CRISPR knockout plants to sclerotinia is significantly lower than that of non-transgenic control plants. The inhibition of BnRLP41 gene expression leads to a significant reduction in the resistance of rapeseed to sclerotinia. The present invention successfully creates and obtains a new rapeseed material with reduced resistance to sclerotinia by constructing BnRLP41-CRISPR gene knockout rapeseed.

[0047] In summary, the present invention combines Figure 1-Figure 2 The results revealed for the first time the positive regulatory effect of the rapeseed receptor gene BnRLP41 on rapeseed's resistance to Sclerotinia sclerotinia, provided the application approach, application technology and implementation examples of BnRLP41 in the creation of Sclerotinia sclerotinia-resistant crop germplasm, and successfully obtained highly resistant Sclerotinia sclerotinia-resistant rapeseed.

Claims

1. An application of a Brassica napus receptor gene BnRLP41 in the prevention and control of sclerotinia sclerotiorum, characterized in that: The nucleotide sequence of the gene BnRLP41 is shown in SEQ ID: 1, and the protein sequence encoded by the gene BnRLP41 is shown in SEQ ID:

2.

2. The use according to claim 1, characterized in that: The application is to obtain rapeseed materials with altered disease resistance by creating transgenic rapeseed (Brassica napus).

3. The use according to claim 2, characterized in that: Application in obtaining rapeseed materials with enhanced resistance to sclerotinia sclerotinia by creating transgenic rapeseed overexpressing BnRLP41.

4. The use according to claim 2, characterized in that: Application in obtaining rapeseed materials with weakened resistance to sclerotinia disease by creating BnRLP41-CRISPR gene knockout transgenic rapeseed.

5. The use according to claim 3, characterized in that: The application of rapeseed materials with enhanced resistance to sclerotinia sclerotinia is achieved by the following steps: (1) Construction and acquisition of BnRLP41 gene overexpression structure The open reading frame of the BnRLP41 gene was cloned into a plant expression vector so that it was expressed under the drive of a strong promoter; (2) Obtaining Agrobacterium transformed with BnRLP41 gene overexpression structure The constructed BnRLP41 gene overexpression structure was transformed into an Agrobacterium strain with strong infection ability to rapeseed by electroporation; (3) Creation and acquisition of transgenic rapeseed overexpressing BnRLP41 The BnRLP41 gene overexpression structure was introduced into rapeseed by Agrobacterium-mediated method to obtain rapeseed transformed with the BnRLP41 gene overexpression structure; (4) Obtaining homozygous transgenic rapeseed lines overexpressing BnRLP41 The antibiotic resistance and BnRLP41 gene expression were used as detection indicators to detect the segregation of the traits of the offspring of the transgenic plants, and the homozygous transgenic rapeseed lines with overexpression of BnRLP41 that could be stably inherited and whose offspring traits no longer separated were obtained; (5) Screening, identification and acquisition of homozygous transgenic rapeseed lines overexpressing BnRLP41 with enhanced resistance to sclerotinia sclerotinia Using the homozygous transgenic rapeseed overexpressing BnRLP41 as material, the resistance to sclerotinia sclerotinia was detected and analyzed, and the transgenic BnRLP41 gene rapeseed with enhanced disease resistance was obtained.

6. The use according to claim 4, characterized in that: The application of the rape material with reduced resistance to sclerotinia sclerotinia is achieved by the following steps: (1) Construction and acquisition of CRISPR knockout construct of BnRLP41 gene A specific sequence fragment of the BnRLP41 gene was cloned into the CRISPR knockout vector pBSbdcas9i to obtain the CRISPR knockout structure pBSbdcas9i-BnRLP41; (2) Obtaining Agrobacterium transformed with the CRISPR knockout construct of the BnRLP41 gene The BnRLP41 gene CRISPR knockout construct was transformed into an Agrobacterium strain with strong infection ability to rapeseed by electroporation; (3) Creation and acquisition of BnRLP41 gene CRISPR knockout rapeseed The CRISPR knockout structure of the BnRLP41 gene was introduced into rapeseed by Agrobacterium-mediated method to obtain rapeseed transformed with the CRISPR knockout structure of the BnRLP41 gene; (4) Obtaining homozygous rapeseed lines with CRISPR knockout of BnRLP41 gene The antibiotic resistance screening method was used to detect the segregation of traits in the offspring of transgenic plants, and the homozygous rapeseed lines with the CRISPR knockout structure of the BnRLP41 gene were obtained, in which the offspring traits no longer separated and could be stably inherited; (5) Screening, identification and acquisition of homozygous rapeseed lines with reduced resistance to sclerotinia sclerotinia by CRISPR knockout of the BnRLP41 gene The homozygous rapeseed line with the CRISPR knockout structure of the BnRLP41 gene was used as the material to detect and analyze the resistance to sclerotinia sclerotinia, and the BnRLP41 gene CRISPR knockout rapeseed with weakened resistance to sclerotinia sclerotinia was obtained.

Citation Information

Patent Citations

  • Increasing plant seed production

    CA2373903A1

  • Plant TMK1 gene and application thereof in sclerotinia sclerotiorum resistance

    CN112029746A

  • Disease-resistant function application of rape gene BnFER1

    CN114317484A

  • Application of rape receptor gene BnRLP26 in prevention and control of sclerotiniose

    CN118910139A

Cited By

  • Application of rape receptor gene BnRLP26 in prevention and control of sclerotiniose

    CN118910139A

  • Application of Brassica Receptor Gene BnRLP26 in Sclerotinia Disease Control

    CN118910139B

  • Chinese cabbage clubroot-resistant gene BrRLP31 and application thereof

    CN121931137A

  • Brassica napus BnaA02.SABATH1 gene and application of brassica napus BnaA02.SABATH1 gene in prevention and control of sclerotiniose of cruciferous crops

    CN122081387A